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Introduction
Mapping of the longitudinal relaxation time, T1, and extra-
cellular volume (ECV) in the human heart has recently shot 
to prominence on the merits of the modified Look–Locker 
inversion recovery (MOLLI) imaging sequence and related 
techniques [1]. These methods allow quantitative tissue 
characterisation in the myocardium, adding new informa-
tion to that provided by T1-weighted techniques such as 
late gadolinium enhancement (LGE) imaging. For focal 
fibrosis, LGE provides excellent delineation of lesions with 
some means of quantifying their volume; however, LGE 
does not give a T1 estimate and may not be able to iden-
tify widely distributed or diffuse myocardial diseases. For 
example, when LGE is applied in diffuse fibrosis, the myo-
cardium can appear isointense and indistinguishable from 
normal myocardium, as multiple uncalibrated factors affect 
the image brightness. These are clear limitations of LGE 
techniques, and in such situations quantitative T1 and ECV 
mapping is advocated [2, 3]. Use of myocardial T1 mapping 
is now widespread, with most MRI manufacturers offering 
T1 mapping solutions. However, great care must be taken 
when applying these methods clinically, given the need for 
protocol optimisation and locally-derived normal ranges.
The accuracy and precision of myocardial T1 map-
ping has been the focus of several studies to date [4–7], 
and has been discussed to some degree in much of the lit-
erature. Innovations in the field are considered in terms of 
their impact on accuracy and precision, typically offering 
trade-offs in one or the other for faster or more-accom-
modating scans. However, there are still several long-
standing pitfalls associated with T1 and ECV mapping 
that affect accuracy and precision, and this review aims 
to give a comprehensive description of these, along with 
potential solutions, with the intent of aiding physicists 
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and clinicians to maximise the clinical utility of T1 map-
ping. Indications will also be given as to what is reasonably 
achievable with myocardial T1 mapping in specific clini-
cal applications, without a full clinical review, for which 
the reader is directed to Haaf et al. [8], Taylor et al. [9], 
Kammerlander et al. [10], and Schelbert and Messroghli 
[11], amongst others. The fundamentals of T1 mapping 
methods, the available pulse sequences, and the history 
of the technique will be discussed briefly, but again read-
ers are directed to more-detailed reviews for full technical 
information: for example, by Kellman et al. [5] and Hig-
gins and Moon [12]. Finally, the consensus statement of the 
Society for Cardiovascular Magnetic Resonance (SCMR) 
and the CMR Working Group of the European Society of 
Cardiology can be consulted for recommendations on how 
to set up a robust T1 mapping protocol [13]. A follow-up 
parametric mapping consensus statement from the SCMR 
and the European Association for Cardiovascular Imaging 
(EACVI) is in preparation.
This review will focus on sources of bias and variabil-
ity in myocardial T1 and ECV estimation: first, technical 
and physiological pitfalls; second, issues relating to con-
trast agents; and third, specific disease-related issues. It 
will conclude with future directions of the field and some 
summary recommendations, including guidance on how T1 
estimation accuracy might be traded for increased clinical 
utility. Within each section, pitfalls will be introduced, their 
mechanisms described, and suggestions offered for how to 
mitigate or eliminate them, along with possible future solu-
tions, where available. For ease of reference, Table 1 lists 
the technical and physiological pitfalls discussed in this 
review in the order they are introduced in the text, with 
summaries of their relative effects on T1 and ECV mapping 
accuracy and precision.
A brief introduction to T1 mapping methodology
All routinely available T1 mapping methods currently rely 
on preparing the longitudinal magnetisation using inversion 
or saturation radiofrequency (RF) pulses, applied to the 
whole imaging volume. Many pulse sequences for T1 map-
ping can be grouped according to the magnetisation prepa-
ration: inversion recovery sequences, including MOLLI 
[1, 14] and shortened MOLLI (ShMOLLI) [15]; satura-
tion recovery sequences, including independent saturation 
recovery single-shot acquisitions (SASHA) [16], saturation 
method using adaptive recovery times for cardiac T1 map-
ping (SMART1Map) [17], and short acquisition period T1 
(SAP-T1) [18]; and mixed preparation sequences, such as 
saturation pulse-prepared heart-rate independent inversion-
recovery (SAPPHIRE) [19]. In practice, a mixture of mag-
netisation preparations and T1-weighted image acquisitions 
are performed during a breath-hold, over several cardiac 
cycles. The aim is to sample the T1 recovery over a range 
of delay times, and pixel-by-pixel curve-fitting is used to 
estimate T1 values. This produces a pixelwise T1 map, often 
with other output maps as quality indicators; see Kellman 
et al. for a flowchart illustrating the pipeline of T1 and ECV 
map generation [20]. Most MRI manufacturers provide in-
line software for map calculation, but open source tools are 
also available [21, 22].
Non-mapping approaches can also estimate T1 in the 
heart: the inversion-recovery cine sequence, also known 
as the Look–Locker cine (LL-cine) technique [23, 24], 
relies on averaged signal intensities over regions of inter-
est (ROIs) for T1 curve-fitting. This approach uses spoiled 
gradient recalled echo (GRE) cine, avoiding the factors 
affecting single-shot balanced steady-state free-precession 
(bSSFP). Note that many studies that have used the LL-
cine method have repeated it at multiple washout times, as 
this improves ECV accuracy [24].
Given its popularity, the original MOLLI sequence will 
be considered the default method in this review, with other 
T1 mapping methods and schemes being addressed where 
appropriate. A common nomenclature for T1 mapping 
schemes will also be adopted [5]. This notation lists the 
number of images acquired following a magnetisation prep-
aration pulse, along with the free-recovery, inter-inversion 
pause in brackets. Timings are given in beats, “b”, or sec-
onds, “s”. For example, 3b(3b)3b(3b)5b uses three Look–
Locker sets, of three beats, three beats, and five beats, 
respectively, with pauses of three R–R intervals between 
each set. A 5s(3s)3s scheme uses two Look–Locker sets 
and a minimum pause of 3 s between these, rounded up to 
the next whole R–R interval.
Technical and physiological sources of error
Look–Locker correction
The original 3b(3b)3b(3b)5b MOLLI sequence [1] and 
subsequent optimised versions rely on Look and Locker’s 
correction for rapid T1 estimation: namely, for sampling of 
the recovering longitudinal magnetisation with a series of 
small-flip-angle excitation pulses [25, 26]. The magnetisa-
tion is perturbed by these excitation pulses, causing flat-
tening of the recovery curve, and yielding an apparent T1, 
known as T1*, when curve fitting:
where S(t) is the signal at time TI after inversion. The 
“true” T1 is usually longer than T1* and can be calculated 
using the so-called Look–Locker correction:
(1)S(t) = A− B exp(−TI
/
T
∗
1 ),
(2)T1 ≈ T∗1 (B
/
A− 1).
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The Look–Locker correction assumes continual rep-
etition of a small flip angle spoiled GRE readout. MOLLI-
based techniques violate the Look–Locker assumptions by 
using: (1) a bSSFP readout, which is sensitive to T2 and, 
weakly, to magnetisation transfer (MT), unlike spoiled 
GRE; (2) a relatively large excitation flip angle, 35° at 
1.5T; and (3) an intermittent sampling scheme, governed 
by heart rate for original MOLLI, to maximise the spread 
of inversion recovery times. Factors (1) and (2) lead to pro-
gressive saturation of the longitudinal magnetisation, caus-
ing a negative T1 bias even after Look–Locker correction. 
Furthermore, Look–Locker sets are separated by pause 
intervals, aiming to allow sufficient recovery of the mag-
netisation prior to the next inversion pulse. If any of these 
pause intervals are too short for the application, be it native 
or post-contrast, this can lead to additional bias in T1 esti-
mates. This can be particularly problematic for fast heart 
rates, as well as longer T1 values, such as in native myocar-
dium at 3T.
Bias resulting from limited magnetisation recovery can 
be mitigated by using an optimised MOLLI acquisition 
scheme: by extending the inter-inversion pause in beats or 
by specifying pauses in seconds rather than beats [4]. The 
2013 SCMR consensus recommends a 5s(3s)3s scheme for 
native T1 mapping and a 4s(1s)2s(1s)1s scheme for post-
contrast acquisitions [13].
Alternatively, saturation recovery methods such as 
SASHA [16] sample the recovering longitudinal mag-
netisation using an independent preparation in each heart-
beat, obviating the need for Look–Locker correction over 
multiple shots at the expense of a loss in precision due to 
a smaller dynamic range of T1 recovery. The saturation 
recovery is still affected during each SASHA single-shot 
readout, but this produces negligible bias in T1 estimates 
obtained from curve fitting of the independent saturation-
recovery images [16, 27].
Partial volume
Partial volume of different tissues within a voxel is preva-
lent in T1 mapping with single-shot imaging, where in-
plane spatial resolution is necessarily somewhat coarse. 
Furthermore, the endo- and epi-cardial borders of the myo-
cardium are often oblique to the imaged slice, especially 
for planes far from the mid-ventricle or in abnormal ven-
tricles. Partial volume can lead to substantial errors, which 
motivates careful ROI delineation on T1 maps [28].
Partial volume causes bias in the apparent T1, especially 
when the tissues included in a voxel have strongly differ-
ent T1 values. Prominent effects occur at the endocardial 
border where the difference in T1 between blood and myo-
cardium leads to overestimation of native T1 estimation in 
subendocardial voxels. Partial volume also occurs between 
myocardium and other tissues, most often fat, whose chem-
ical shift causes variable bias in the pixel T1 [29]; this has 
clinical relevance, and is discussed further in the “Errors in 
specific clinical applications” section.
Finer in-plane resolution of the T1 mapping sequence 
would theoretically reduce partial volume effects, but 
demands longer single-shot imaging duration if no trade-
offs are made, increasing the risk of cardiac-motion blur-
ring. Parallel imaging and partial Fourier in the phase-
encode direction are commonly employed to allay this 
problem. It is essential to avoid partial volume when draw-
ing regions of interest (ROIs), which are often limited to 
mid-wall when possible [28, 30]. Cardiac motion during 
the single-shot imaging also corrupts myocardial signal 
with blood signal in less obvious ways, and is discussed 
later.
“Black-blood” T1 mapping aims to eliminate blood 
partial volume for improved T1 estimation accuracy [31], 
whereby the magnetisation of flowing blood is nulled by 
motion-sensitive dephasing immediately before each sin-
gle-shot image. Multiecho fat-water-separated imaging 
strives to separate fat signal from the thin RV [32], and has 
been combined with the same method of blood suppression 
[33]. However, these approaches are not routinely reliable.
To achieve finer spatial resolution, and thus reduce the 
impact of partial volume in source images on pixelwise 
mapping, segmented k-space image acquisition over mul-
tiple cycles is required, and is often combined with some 
undersampling strategy [34, 35]. Segmented acquisition is 
severely affected by R–R variability in inversion-recovery 
methods, and is very slow to acquire the fully recovered 
image in saturation-recovery methods. The non-mapping 
LL-cine approach can acquire fine spatial and temporal res-
olutions, but cardiac motion occurs during recovery, rais-
ing questions about the impact of through-slice motion, and 
substantial post-processing labour is required to optimise 
ROIs used for curve-fitting and regional estimation of T1.
Finally, free-breathing T1 mapping methods promise to 
reduce intershot-motion-related errors [36–39]. However, 
these methods are currently time-consuming.
Factors affecting magnetisation preparation pulses  
(B1, B0, T2)
The fitting models used in T1 mapping usually assume 
exact inversion or saturation of the longitudinal magnetisa-
tion, or fit an extra parameter instead, reducing precision. 
Another approach uses prior knowledge of an inversion 
factor, which can be estimated from fully relaxed reference 
images to correct the estimated T1 [40–42].
Conventional RF pulses require accurate RF transmit 
(B1) fields to achieve their prescribed flip-angle, so are 
sensitive to B1 inhomogeneity, which can be substantial 
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across the heart, particularly at 3T [40, 43]. The flip-angle 
achieved by conventional non-selective RF pulses is also 
affected by off-resonance errors due to B0 inhomogeneity. 
Therefore, adiabatic inversion pulses or composite satu-
ration pulses are widely used for mapping to reduce sen-
sitivity to both B0 and B1 inhomogeneity [40, 44]. How-
ever, the longer duration of some adiabatic pulses can 
increase T2 decay during their execution and introduce 
sensitivity to off-resonance phase accumulation. Kell-
man, Herzka, and Hansen suggest the use of a relatively 
short tan/tanh adiabatic pulse for optimal inversion effi-
ciency [40] (Fig. 1), while a composite saturation design 
is recommended for saturation-recovery methods such as 
SASHA, provided the higher specific absorption rate and 
pulse duration are acceptable [44]. Optimised saturation 
precision, or efficiency, is important in SASHA for two 
reasons: (1) to enable two-parameter curve-fitting for T1 
estimation, as opposed to fitting of saturation efficiency 
as a third parameter; and (2), reliable removal of any his-
tory effect from previous cycles by nulling the longitudi-
nal magnetisation prior to each independent shot.
Although the aforementioned RF pulse designs are 
more tolerant to B0 and B1 errors, for mapping it is vital 
to optimise both B0 and B1 over the relevant volume. 
See Fig. 2 for examples of B0 and B1 maps, in vivo. The 
advent of RF (B1) shimming hardware with optimised 
volume calibration methods has enabled substantial 
improvements in B1 uniformity over the heart [45] even 
with only two whole-body transmitter channels [46].
Inversion‑recovery multishot bSSFP
Most T1 mapping methods use bSSFP to sample the recov-
ering longitudinal magnetisation, as this method offers 
a higher signal-to-noise ratio (SNR) than spoiled GRE. 
However, bSSFP is sensitive to T2 and off-resonance, 
where both sensitivities are modulated by excitation flip-
angle, RF pulse repetition time (TR), and magnetisation 
transfer [47]. These factors have greater impact on esti-
mated T1 when the bSSFP flip angle is higher or the TR is 
longer, and native myocardial T1 values are more affected 
than the shorter post-contrast T1 values. Off-resonance is 
larger at 3T, mitigated by use of a lower flip angle [48], 
but reducing T1 error through use of a shorter TR is largely 
limited by patient peripheral nerve stimulation [49].
Another consideration with bSSFP is the transient period 
before the steady-state is established, which is character-
ised by oscillatory magnetisation, causing image artefacts. 
The intensity of the oscillations depends on both the bSSFP 
catalysation used to stabilise the signal, and the k-space tra-
jectory [50].
Catalysation sequences for bSSFP
For T1 mapping, some single-shot bSSFP images at short 
inversion-recovery times are required for optimal curve-fit-
ting, although for SASHA a later start is preferred, as ear-
lier readouts have low SNR [27]. Short delay times prevent 
stabilisation of the bSSFP signal before phase-encoded 
data acquisition commences, and since all shots should be 
acquired with identical parameters, a longer stabilisation 
for the later inversion-recovery shots is inadvisable.
Fig. 1  Inversion pulse performance. Plots show the response to 
B0 (vertical) and B1 (horizontal) of two different adiabatic inver-
sion pulse designs: Hyperbolic Secant and Tan/Tanh (T1 = 1000 ms, 
T2 = 45 ms). A contour value −1.0 would indicate perfect inversion. 
The “design region”, enclosing the maximal likely in vivo cardiac B0 
and B1 distortion, is represented by the dotted green box. Adapted 
with permission from Kellman et al. [40]
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Several catalysation or “priming” sequences are used 
in bSSFP to accelerate the signal’s approach to the steady 
state, and these are particularly important in T1 mapping’s 
limited time window before image data must be acquired, 
especially for centre-out k-space ordering, which is dis-
cussed later. Catalysation details may be concealed from 
the scanner’s user interface, and may change through soft-
ware upgrades without warning. Schemes include half-
alpha [51], and linear ramp-up [52] (see Fig. 3); the type 
and duration of the scheme affects T1 estimation accuracy 
and precision, with bias errors of the order of 5% or more 
for some approaches [53].
The linear sweep up scheme is a good approach, as this 
sufficiently quells oscillatory behaviour prior to k-space 
filling [53].
Impact of T2 on estimation of T1 by bSSFP readouts
Shorter T2 relaxation times are associated with underesti-
mation of T1 due to the T2/T1 weighting of bSSFP [5, 43], 
and their effect on preparation pulses. The Look–Locker 
sets of MOLLI sequences are more sensitive to T2 than 
the independent images used in saturation methods like 
SASHA, due to accumulated T2-related saturation between 
single-shot images in each set [54]. When T2 is long, 
such as in left ventricular blood, MOLLI estimation of T1 
increases towards the true value.
In addition to low flip angles and short TR, coarser 
acquired resolution in tandem with parallel imaging and 
partial Fourier in the phase-encode direction can reduce the 
length of the bSSFP pulse train and thus mitigate T1 esti-
mation bias resulting from T2-related saturation.
Impact of off‑resonance on bSSFP readouts
A disadvantage of bSSFP is its sensitivity to off-resonance 
[55], which causes dark banding artefacts and associated 
T1 errors; however, off-resonance errors in estimated T1 
can also occur in myocardial regions without banding arte-
facts. The inferolateral segment is particularly vulnerable 
to this problem. Furthermore, the off-resonance sensitivity 
of bSSFP is also influenced by the catalysation sequence 
used, as shown in Fig. 3.
The sensitivity to off-resonance is not identical across all 
of the bSSFP source images. Given that single-shot bSSFP 
is not fully stabilised for T1 mapping sequences, the impact 
of off-resonance varies at different points on the T1 recov-
ery curve, and so does not cancel out of the curve-fitting 
estimation of T1 [48]. ECV measurements are less strongly 
affected by off-resonance than native T1 estimates, showing 
a bias error of around 1% or less [48].
Off-resonance errors can be reduced through volume B0 
shimming over the heart and great vessels; however, even 
if second-order B0 shimming is carefully optimised, it can-
not correct very local B0 distortions (Fig. 2a). Investigators 
should familiarise themselves with B0 shimming routines 
on their scanner, considering factors such as cardiac gating 
and respiration, among others. Projection-based shimming 
algorithms [56] are widely available; however, image-based 
shimming methods [57, 58] may offer better control over 
local B0, and they provide B0 fieldmaps that can assist qual-
ity control of T1 studies.
Off-resonance distortion of T1 can be reduced by lower 
flip-angles and/or a shorter TR. For example, a coarser fre-
quency-encode resolution may reduce TR; however, this 
Fig. 2  In vivo fieldmaps of static field and radiofrequency trans-
mit homogeneity in the heart. Plots show a B0 map (a) and a B1 
map (b) planned across the mid-ventricular short axis of the heart, 
with dashed red lines delineating the approximate boundaries of the 
myocardium. Maps were acquired at 3T, subsequent to first-order B0 
shimming and dual-channel RF calibration. Note the distinct inho-
mogeneity of B0 near the coronary veins in a (arrows), and slightly 
reduced pulse performance across the right ventricle in b, where the 
measured B1 drops to around 50–60% of the nominal value
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may also automatically modify the phase-encode resolution, 
reducing the number of RF pulses before the centre of k-space 
and affecting stabilisation. Furthermore, coarser frequency-
encode spatial resolution increases partial volume. Any such 
changes require attention with regards to effects on estimated 
T1 and possible invalidation of normal range data [13].
A recent development substituted MOLLI’s bSSFP read-
out with a spoiled GRE sequence [59], which avoids the 
more complex sensitivities of bSSFP, improves T1 estima-
tion accuracy, and reduces the sensitivity of T1 estimation 
to T2. It has also been applied in patients with implanted 
devices that cause severe off-resonance artefacts, preclud-
ing bSSFP imaging [60]. However, these benefits come 
with several disadvantages: spoiled GRE shows reduced 
SNR versus bSSFP; its T1 estimation precision is also 
reduced; and adequate spoiling may be difficult. Spoiling 
has been shown to be problematic for the variable flip angle 
method [61], but may be less so for inversion-recovery 
based T1 mapping [59].
Schemes for k‑space filling
To date, most T1 mapping has used linear phase-encode 
ordering, where phase-encoding gradient amplitudes are 
stepped through incrementally. This avoids eddy-current-
related signal perturbations, but causes progressive T2-
related saturation in the approach to the centre of k-space, 
leading to T1 underestimation. Alternatively, centric phase-
encode ordering, also known as the centre-out or low–high 
approach, fills k-space from the centre outwards with alter-
nating and increasing phase-encoding gradient amplitudes; 
this avoids the T2-related saturation of linear ordering at the 
expense of increased eddy-current-related artefacts [53].
Although linear-ordering is typically used, several other 
phase-encode ordering schemes have been investigated to 
date [43, 53, 62]. Paired phase-encoding has been proposed 
to mitigate the artefacts associated with centric ordering 
[63]; however, it has shown mixed results for T1 mapping 
[53, 62], performing well only with longer catalysation 
schemes.
Signal‑to‑noise
All T1 mapping methods acquire multiple T1-weighted 
source images, each of which has its own SNR per tissue, 
and the noise level will influence the sampled points during 
curve-fitting. The fewer T1-weighted source images used to 
reconstruct a T1 map, the poorer the curve-fit conditioning 
Fig. 3  The effect of balanced steady-state free-precession cataly-
sation sequences on native T1 maps. Plots show the effect of linear 
ramp-up (a) and half-alpha (b) catalysations on the magnetisation 
evolution (i) and frequency response at the centre of k-space (ii) of 
balanced steady-state free-precession at 3T. Short axis, mid-ventricu-
lar native T1 maps are shown for each method (iii). Simulations were 
performed with a repetition time of 2.8 ms, a flip angle of 35°, a T1/T2 
of 1200/45 ms, and 10 catalysation pulses for each method, with a 
further 39 pulses before the centre of k-space
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and the poorer the T1 estimation precision [15]. Given the 
limited number of shots taken throughout longitudinal 
recovery, their optimum distribution in comparison to the 
relevant range of T1 is also important, motivating different 
sequence schemes for native and for post-contrast mapping 
[5, 27].
SNR varies spatially across the heart, predominantly due 
to the sensitivity profile of the receiver coil array. Low SNR 
is most evident in the lateral wall, which is farthest from the 
coil, and thus this region is more prone to noise-related T1 
estimation bias and dispersion [4]. This effect is in addition 
to susceptibility artefact seen in the lateral wall—another 
reason why clinical T1 measurements for assessment of dif-
fuse fibrosis are often confined to the interventricular sep-
tum [30].
Imaging at higher field strengths can mitigate errors 
resulting from low SNR, as shown by Piechnik et al. [15], 
who reported approximately 30% reduction in coefficients 
of variation for MOLLI and ShMOLLI T1 estimates when 
moving from 1.5 to 3T. Conversely, 3T exacerbates off-res-
onance and B1 inhomogeneity effects, though their impact 
can be controlled.
Influence of field strength
In addition to the aforementioned off-resonance and B1 
inhomogeneity issues at higher field strengths, and the 
potentially increased SNR, there are also differences in 
native T1 and T2 values between 1.5 and 3T.
A large multicentre study of native T1 and ECV values 
in normal myocardium, using original 3b(3b)3b(3b)5b 
MOLLI, reported mean (standard deviation) native T1 val-
ues of 950 (21) ms at 1.5T and 1052 (23) ms at 3T, and 
mean (standard deviation) ECVs of 0.25 (0.04) at 1.5T and 
0.26 (0.04) at 3T [64]. The increased T1 at 3T can lead to 
insufficient longitudinal recovery between Look–Locker 
sets, causing T1 underestimation; furthermore, reduced 
myocardial T2 at 3T relative to 1.5T introduces additional 
negative bias due to the T2/T1 weighting of bSSFP and sig-
nal decay during preparation pulses [5].
Increased B0 and B1 inhomogeneity at 3T can be miti-
gated using appropriate B0 and RF shimming, respectively. 
Shallower excitation flip angles can also allay these effects, 
if the increased SNR at 3T is traded off [5].
Breath‑holding
Currently, T1 mapping requires breath-holding to minimise 
respiratory motion while source images are acquired. Orig-
inal MOLLI used a breath-hold duration of approximately 
17 cardiac cycles [1], while newer variants require around 
10 or 11 s [4]. A shorter breath-hold is an advantage in rou-
tine work [15], but it causes a reduction in SNR. Imperfect 
breath-holds typically lead to misregistered source images, 
which corrupt the set of signal intensities used for pixel-
by-pixel curve fitting and, in turn, decrease T1 estimation 
accuracy and precision. Often, misregistration is not readily 
apparent in calculated T1 maps, unless a confidence-map is 
provided alongside or overlaid on the T1 map. See Fig. 4 
for an example of this.
Post-acquisition quality control has some aspects in 
common for respiratory motion and cardiac misgating or 
arrhythmia: T1 mapping source images should be exam-
ined carefully for displacements, even if motion-corrected 
images are also available. Mislocated tissue in or through 
the selected slice, for any of the shots, may preclude correct 
mapping of localised disease, such as myocarditis. If sig-
nificant displacements are found, nonrigid registration may 
register most myocardial pixels [20, 65], but cannot correct 
through-slice displacement. Input image registration in T1 
mapping is challenging due to the large image-contrast var-
iations between source images, and can be unreliable when 
tissues are imaged near the null point of longitudinal mag-
netisation recovery. While there are strategies for dealing 
Fig. 4  An example of motion-related T1 estimation error shown on 
quality control maps. A short-axis native T1 map corrupted by res-
piratory motion (a) demonstrates excessive pixelwise curve-fitting 
residual errors, indicated on a confidence map (b) by the addition of 
marked pixels to the same map shown in a
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with this issue [65], motion-corrected images should be 
reviewed before drawing ROIs on the T1 map. This issue is 
another reason why midwall, septum-only ROIs tend to be 
more reliable.
Free-breathing T1 mapping acquisitions have been 
reported [34, 36–39], and aim to automatically exclude 
images with large misregistrations. While this may be more 
feasible for independent images, as used in SASHA [16], 
the impact of poor breath-holding or misgating variations 
on the later points of a Look–Locker set is convoluted. Fur-
thermore, these methods can extend scan time, and often 
employ undersampling.
Cardiac triggering and cardiac motion
Source images for mapping must be acquired in the same 
phase of the cardiac cycle to ensure registration for pixel-
wise T1 map calculation.
Some variation in R–R interval is normal, and MOLLI-
variant sequences record the real-time R–R increments to 
the inversion-recovery time during each Look–Locker set. 
Arrhythmia may be tolerable provided the trigger to the 
pulse sequence is followed by a reasonably normal ventric-
ular contraction and diastolic pause (diastasis). If arrhyth-
mia interferes with diastolic timing, it is feasible to acquire 
the single-shot images in end-systole [66, 67]. The end-sys-
tolic duration is less dependent on heart rate than diastasis, 
and may offer improved accuracy and precision in arrhyth-
mia. Partial volume may also be less of an issue, as the 
contracted myocardium is thickened; however, the brevity 
of the end-systolic pause necessitates a shorter single-shot 
image readout, and thus spatial resolution is coarser.
A slightly shorter native T1 has been reported for map-
ping at end systole versus end diastole [66, 67]; however, 
this relationship flips after contrast administration, impact-
ing ECV [68]. The cardiac phase of the image does not 
imply that the entire, usually slower, T1-relaxation process 
is sensitive to the myocardial relaxation or contraction state 
at the time of the image.
Similar to respiratory motion, cardiac mistriggering 
causes mis-registration of source images for T1 mapping. 
Again, an elastic image registration algorithm may be able 
to account for this, but source images should be checked 
rigorously. If mis-registration goes uncorrected, distortion 
of fitted T1 recovery curves is likely, particularly in the 
subendocardium. For this reason, some types of cardiac 
arrhythmia can be a major problem, but novel methods 
promise robust performance in such conditions [69].
The single-shot imaging duration should not exceed the 
length of the cardiac pause, be it diastolic or systolic. Tong 
et al. empirically estimated that the shot duration should not 
exceed 150 ms for minimal cardiac motion artefacts [70]. It 
is relatively straightforward to plan single-shot imaging to 
coincide with the required cardiac phase, as timings can be 
measured from a bSSFP cine acquired during routine setup, 
or may be semi-automated [71].
The image-readout duration can also be reduced using 
parallel imaging methods that acquire coil profiles sepa-
rately: namely, before the scan or immediately after the last 
single-shot image. Note a related pitfall with coil profiles 
or any other prescan applied immediately prior to a T1 map-
ping acquisition is that the longitudinal magnetisation may 
not have recovered before the first inversion [48], though 
this is usually avoided with a pause for breath hold instruc-
tion to the patient.
Flowing blood
Measurement of blood T1 is important for the calculation 
of ECV. Complications in Look–Locker correction arise 
for blood that is at least partially replaced by fresh wash-in 
in the image slice for each cardiac cycle. Completely 
“fresh” blood, while still acted upon by the initial non-
selective inversion, has not experienced previous shots of 
the current Look–Locker set since inversion and, therefore, 
does not require Look–Locker correction. However, even a 
normal heart ejects only around 55–75% of left ventricu-
lar blood per cycle [72], so the true situation is probably 
a complex mixture of different magnetisation histories in 
left-ventricular blood. Furthermore, in the extreme case, for 
later images of a native T1 mapping acquisition the arriv-
ing blood may have experienced a distorted magnetisation 
preparation at some upstream location, despite application 
of optimised preparation pulses. This can occur in short 
bore scanner systems [5], or in unusual flow pathways fol-
lowing repairs of congenital heart defects.
Magnetisation transfer (MT)
When estimating T1 in the myocardium and blood pool, it 
is also important to consider the MT phenomenon, which 
has been shown to influence the accuracy of T1 mapping [5, 
47]. Exchange between free and bound water pools within 
the tissue of interest reduces the bSSFP signal [73]. For 
inversion-recovery-based T1 mapping, the bound pool is 
mostly unaffected by the inversion pulse, so exchange dur-
ing the long inversion-recovery delays distorts the shape of 
the T1 recovery curve and introduces T1 underestimation. 
The extent of this effect varies between tissues, and is sub-
stantially smaller in blood than in myocardium [5, 74].
The MT effect can be allayed by using SASHA with 
a three-parameter curve-fit, at the expense of reduced T1 
estimation precision. It can also be mitigated in inversion-
recovery T1 mapping by use of lower-flip-angle excitation 
pulses and a longer imaging TR. Alternatively, the MT 
effect could be exploited in native T1 mapping for greater 
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disease discrimination in pathologies such as myocardial 
infarction (MI), ischaemia, and iron overload—all of which 
have all demonstrated MT.
Summary of technical pitfalls
Each technical and physiological challenge listed here may 
cause errors in T1 and ECV mapping, increasing bias, scat-
ter, or both. Cardiac and respiratory motion are particularly 
problematic, and strict quality control routines may help 
correct these where possible. At 3T, inhomogeneous B0 and 
RF transmit fields also become prominent sources of error, 
which may be mitigated with appropriate B0 shimming and 
RF transmit calibration. However, despite these prominent 
pitfalls, no issue dominates, and with considerable exper-
tise, care, and attention to multiple factors, users can miti-
gate many sources of error, with the level of optimisation 
depending on their specific clinical or research applications.
Contrast agents
Gadolinium-based contrast agents (GBCAs) in myocardial 
T1 mapping are subject to their own issues and controver-
sies for deriving estimates of myocardial ECV. This section 
discusses the various assumptions made about GBCAs in 
T1 and ECV mapping.
Assumptions relating to contrast agents
Several basic assumptions regarding GBCA estimation of 
ECV are stated here first, with further details later. Strictly, 
we assume that the contrast agent has identical relaxivities, 
r1, in myocardium and blood pool:
where R1,myo and R1,blood are the changes in relaxation 
rates in myocardium and blood, respectively, and [Gd] rep-
resents the concentration of GBCA, typically in millimole/
litre units [75, 76]. The change in relaxation rate, R1, is 
given as:
If we assume that r1,myo = r1,blood, as stated above, then:
where the ratio [Gd]myo
/
[Gd]blood is the partition coeffi-
cient, λ [75, 77].
(3)R1,myo = r1,myo[Gd]myo
(4)R1,blood = r1,blood[Gd]blood,
(5)R1 =
(
1
/
T1
)
postGad
−
(
1
/
T1
)
native
.
(6)
R1 = r1[Gd]→ R1,myo
/
R1,blood = [Gd]myo
/
[Gd]blood,
Secondly, we assume that the GBCA does not enter 
myocytes or blood cells, and that it is instead in dynamic 
equilibrium of water relaxation inside those cells, because 
of fast-exchange of water through cell walls, as follows:
where Hct is the haematocrit. The term “fast” implies fast 
exchange of enough water across cell walls relative to the 
relevant T1 range late after the myocardial first-pass.
Both amyloid deposition and collagen accumulation in 
fibrosis increase the interstitial space and break up myocyte 
packing. Collagen itself is of negligible non-permeated or 
“dark” volume (very short T2), and is assumed to be highly 
permeable to interstitial fluid, including the GBCA. If the 
GBCA did not enter the collagen volume, but achieved 
relaxation equilibrium with it by fast exchange, it would 
manifest as an abnormally low ECV, resembling myocyte 
hypertrophy.
Finally, late after injection we assume that the concen-
tration of GBCA in the interstitial fluid is equal to that in 
the blood plasma [77], and we calculate ECV as follows:
as described by Messroghli et al. [78].
Contrast agent types
Several GBCAs are available for T1 mapping applications, 
including gadopentetate dimeglumine (Gd-DTPA), gado-
benate dimeglumine (Gd-BOPTA), and gadobutrol; these 
are known under the trade names “Magnevist”, “Multi-
hance”, and “Gadovist”, respectively. Each agent has dif-
fering relaxivities and binding properties, which can lead 
to differences in the estimated ECV; further complica-
tions arise due to relaxivity variations with different field 
strengths.
The Gd-BOPTA agent’s aromatic ring enables weak 
plasma protein binding, leading to a lower molecular tum-
bling rate and thus a longer rotational MR correlation time 
and higher relaxivity in blood plasma and myocardial inter-
stitial fluid compared to Gd-DTPA and gadobutrol. Further-
more, a lower dose of Gd-BOPTA has been shown to have 
similar diagnostic efficacy to a higher dose of Gd-DTPA 
in LGE imaging of MI [79]. Kawel et al. have shown that 
the use of Gd-DTPA leads to myocardial T1 values around 
15 ms lower than Gd-BOPTA, with no statistically sig-
nificant difference seen in blood pool [80]. This results 
in slightly greater ECV values measured by Gd-DTPA, 
(7)[Gd]myo = [Gd]interstitial × ECV
(8)[Gd]blood = [Gd]bl_plasma × (1− Hct),
(9)
[Gd]interstitial = [Gd]bl_plasma → ECV = (1− Hct)
×�R1,myo
/
�R1,blood,
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of the order of 0.01, perhaps due to Gd-BOPTA’s bind-
ing to human serum albumin, which is responsible for its 
increased relaxivity. With regards to relaxivity variations 
with field strength, work by Rohrer et al. and Pintaske et al. 
has illustrated the variability in R1 of GBCAs in human 
blood plasma for different contrast agent types and at dif-
ferent field strengths [81, 82], which will lead to bias and 
variability in ECV measurements if not accounted for.
The relatively greater presence of albumin in blood ver-
sus myocardium means the distribution of protein-bound 
contrast agent between these pools is likely to be different 
than for non-protein-bound equivalents, altering the ratio 
of the change in relaxation rate of myocardium and blood 
and thus altering ECV. Given that this distorts one of the 
assumptions of in gadolinium-based ECV estimation, use 
of a protein-bound contrast agent will slightly modify parti-
tion coefficient estimation by T1 mapping. If investigators 
plan to use one of these agents, they should do so consist-
ently, and report this clearly in any inter-site comparisons.
Steady‑state contrast versus bolus administration
The method of contrast administration also introduces vari-
ability to ECV calculation. Under most conditions, the two-
compartment steady-state assumption, stated in Eq. (9), 
holds true for single bolus administration [83–85]. Early 
work in ECV used a primed infusion approach, whereby an 
initial loading bolus is followed by a continuous infusion 
of GBCA [86]. For most situations, the simpler bolus-only 
approach gives a similar ECV; however, for ECV greater 
than 0.4, in myocardial infarction (MI) and amyloidosis 
for example [87], it substantially overestimates ECV [84]. 
In a third method, several T1 mapping acquisitions can be 
acquired during GBCA washout for improved accuracy in 
estimating the gadolinium blood-myocardium partition 
coefficient [24, 88, 89], which is estimated through the slope 
of a linear fit to myocardial R1 versus blood R1. The parti-
tion coefficient has been shown to deviate from this model 
in the early washout phase [90, 91], causing underestima-
tion of ECV. This can be seen in Fig. 5, where data become 
markedly non-linear for blood R1 values greater than 4 s−1; 
these data are often excluded from ECV calculations to 
avoid bias (Jerosch-Herold, personal communication).
Fast exchange assumption
Equations (7) and (8) are dependent on the fast exchange 
assumption, whereby we assume that water exchange 
between intracellular and extracellular compartments is suf-
ficiently fast relative to the difference between the relaxation 
rates of the compartments considered in isolation [75]. In 
cases where this assumption is broken, where higher GBCA 
concentrations are used or post-GBCA measurements are 
made too early, as discussed above, ECV may be underesti-
mated [92]. Regardless, in typical clinical T1-mapping situa-
tions, it appears that the fast-exchange assumption is sound.
Use of blood T1 to calculate haematocrit
The blood for haematocrit assessment should be taken 
contemporaneously with T1 mapping [13], to avoid 
unnecessary scatter in ECV. Synthetic haematocrit has 
recently been proposed as a means of streamlining ECV 
calculation [93]; it is calculated using the linear relation-
ship between native blood T1 and blood-analysed haem-
atocrit. Support for this approach is spreading [93, 94]; 
however, several issues have been identified that should 
be considered [95, 96].
Fig. 5  Estimation of partition coefficient in chronic myocardial 
infarction patients. Plots show myocardial relaxation rate (R1) ver-
sus blood R1 in viable and infarcted myocardium (red and black 
points, respectively) for two different post-contrast serial acquisition 
schemes. Note that the slopes of the linear regressions (partition coef-
ficients, λ, indicated by dotted lines) change considerably depending 
on the sampled points (crosses) for infarcted tissue, but remain rela-
tively constant in viable myocardium. Plot (a) used time points from 
1 to 40 min for partition coefficient estimation, which gave λ = 0.46 
in viable myocardium and 0.38 in infarct. Plot (b) used time points 
from 15 to 40 min for linear regression, leading to λ = 0.49 in viable 
tissue and 0.86 in infracted tissue. Dashed grey lines indicate the cut-
off R1 of 4 s−1, above which points are generally excluded to avoid 
nonlinearity of λ (Jerosch-Herold, personal communication). Adapted 
with permission from Goldfarb and Zhao [90]
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Summary of contrast agent issues
Although there are multiple issues with contrast agent 
types and field-strengths, none of these appear to dominate. 
There perhaps remains a dilemma between optimal ECV 
assessment and clinical feasibility: for example, the use of 
multiple acquisitions during GBCA washout, along with 
multiple averages for native T1 scans, will improve ECV 
accuracy and precision, but such a protocol is difficult to fit 
into busy clinical schedules.
Errors in specific clinical applications
The aim of this section is to highlight the impact of the 
above topics in specific clinical applications, with examples 
and possible solutions.
Differences in age, sex, and myocardial region
There appear to be subtle differences in native myocardial 
T1 related to sex and age, though there is currently no con-
sensus on whether these also influence ECV [28, 64, 97–
99]. Several investigators have posited theories as to why 
native T1 and ECV might increase or decrease with age, 
but the debate over these issues is outside the scope of this 
review. We should, however, point out that these changes 
are small, and demonstrable only over large groups, with a 
similar scatter to T1 and ECV estimates in diffuse fibrosis, 
which are discussed later.
Regarding myocardial region, there appears to be no sta-
tistically significant difference between native T1 measure-
ments in the basal, mid, and apical regions of the left ven-
tricle in healthy volunteers [100]. Several studies, however, 
have reported lower native T1 values in the lateral wall ver-
sus the inter-ventricular septum [30, 64, 68, 97, 101]. It is 
likely this is mainly due to technical confounds rather than 
physiological differences, as cardiac motion, off-resonance 
by local B0 distortion, and lower coil sensitivity all reduce 
accuracy and precision in the lateral wall. ECV, on the 
other hand, does not differ significantly between the lateral 
wall and septum [97], suggesting that reduction of native T1 
by off-resonance is likely the main source. Figure 6 illus-
trates the variation of native T1 throughout the heart; lower 
T1 values are seen in inferolateral segments, which typi-
cally demonstrate off-resonance due to interfaces with the 
lung and the posterior vein of the left ventricle [102, 103].
Routine clinical applications of T1 and ECV mapping
Myocardial T1 and ECV mapping has attracted a lot of 
interest for both clinical and research applications due to 
its potential for accurate and precise tissue characterisation 
on a pixel-by-pixel basis. While T1 mapping still shows 
promise for aiding precision medicine and influencing 
management of individual patients, recent work has been 
more pragmatic, with applications focusing on large patient 
populations and specific conditions.
Cardiac amyloidosis
Amyloid is a relatively rare multi-system condition where 
deposition of misfolded fibrillary protein in tissues and 
organs can cause expansion of the myocardial extracel-
lular space and impairment of cardiac function [104]. 
This strongly increases native T1 and ECV globally, with 
minimal overlap with healthy ranges [84], making them 
an excellent diagnostic tool [105]. Post-contrast T1 map-
ping can also be helpful in highlighting abnormal GBCA 
washout kinetics, which show a specific pattern in amyloid 
patients [106], and a higher ECV in this context indicates 
a worse prognosis [107]. With large global changes and no 
concerns regarding myocardial region, this combination 
enables T1 mapping to deliver strong diagnostic and prog-
nostic utility.
Anderson‑Fabry disease
Another rare multi-system syndrome, Anderson-Fabry dis-
ease (AFD) is characterised by intracellular accumulation 
of glycosphingolipids. This leads to progressive cardiac, 
renal, and cerebrovascular disease [108], and thus early 
diagnosis is extremely important for timely intervention. 
AFD markedly reduces global myocardial native T1 com-
pared to healthy volunteers, and thus represents a strong 
application of native T1 mapping [109–111], again without 
concerns about regional myocardial differences. For several 
reasons, the reduced global native T1 in AFD likely does 
not result directly from the short T1 of fat [109], contrast-
ing with apparent local T1 increases sometimes seen in fatty 
infiltration of chronic MI, which is discussed later.
Myocarditis and Takotsubo cardiomyopathy
Myocarditis and Takotsubo cardiomyopathy are also 
potential clinical applications for T1 mapping [112, 113], 
being characterised by myocardial oedema, among sev-
eral other markers. Oedema can be clearly highlighted 
on native T1 maps due to increased interstitial fluid con-
tent; indeed, native T1 mapping has higher diagnostic 
accuracy for identifying oedema than T2-weighted imag-
ing in Takotsubo [113, 114], and myocarditis [115]. In 
this application, although native T1 is strongly increased, 
this is often sharply localised in myocardium, and 
thus operators should take care to localise to the rel-
evant myocardial region. Furthermore, understanding 
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of localised technical pitfalls is also valuable: such as 
off-resonance, whose impact is further modulated by B1 
changes over the heart. It should be noted that published 
studies have typically excluded patients with major epi-
cardial coronary disease or past MI. For T1 mapping to 
become clinically meaningful in myocarditis and Takot-
subo, it should not only positively confirm the diagnosis, 
but also rule out acute MI.
Potential clinical applications of T1 mapping
In some pathologies, T1 and ECV currently demonstrate 
limited sensitivity, but may ultimately be of clinical util-
ity if their precision is improved, or if confounds are 
addressed.
Acute myocardial infarction
Like myocarditis and Takotsubo, acute MI also presents 
with oedema, which leads to elevated local T1 on native 
T1 maps [116–118]. There are, however, potential T1 
mapping pitfalls in acute MI, additional to that of local 
disease. Firstly, microvascular obstruction, or the “no 
reflow” phenomenon [119], causes derangement of the 
microvasculature, limiting blood flow post-reperfusion. 
This can distort an earlier assumption for ECV deriva-
tion, that of GBCA equilibrium between the infarct zone 
and the blood plasma. In particular, the necrotic core of 
the infarct will not be in equilibrium 15–20 min post-
bolus, requiring infusion for accurate ECV measurement 
[84].
Secondly, myocardial haemorrhage often occurs con-
comitantly with microvascular obstruction [120], and is 
characterised by extravasation of red blood cells through 
gaps in the endothelial walls. This leads to a cascade of hae-
moglobin decay products in the no reflow region during the 
weeks following reperfusion, with various iron states affect-
ing T2, estimated T1, and true T1 [121]. Clearly this poses 
problems for T1 mapping, and thus CMR studies should be 
timed appropriately after reperfusion therapy [122].
Chronic myocardial infarction
For T1 mapping, chronic MI presents the challenge of lipo-
matous metaplasia, which affects around 24–47% of MI 
patients [29, 123]. This is characterised by fatty infiltration 
Fig. 6  Regional variation in native T1 estimates. Graph (a) shows 
variability in segmental native T1 across 16 myocardial segments in 
subjects with normal left ventricular function (solid red line, n = 27) 
versus subjects with non-ischemic cardiomyopathy (dashed blue line, 
n = 39). Error bars represent the standard error of the mean. Base, 
mid, and apex refer to levels of the left ventricular myocardium, and 
segments 2, 3, 8, 9, and 14 are septal, as illustrated by the American 
Heart Association model (b). Inferolateral segments show the low-
est native T1 values, likely due to off-resonance at interfaces with 
the lung and the posterior vein of the left ventricle. The approximate 
territories of the right coronary artery (RCA) and the left anterior 
descending (LAD) and left circumflex (LCX) arteries are also shown 
for interest. Graph (a) is reproduced with permission from Shah et al. 
(2016) Am J Cardiol 117(2): 282–288
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of myocardium, highlighting the following technical diffi-
culty with fat partial volume in T1 mapping.
Ignoring bSSFP characteristics, a mixture of in-phase 
lipid and water signals within a voxel produces a biexpo-
nential T1 recovery curve. Attempting to fit these data with 
a monoexponential curve typically leads to lower myocar-
dial T1 estimates due to inclusion of short T1 lipids, which 
have T1 values around 370 ms at 1.5T and 450 ms at 3T 
[124]. However, in myocardial T1 mapping the mono- 
versus bi-exponential “model mismatch” issue is usually 
not the dominant factor, because most T1 mapping uses 
bSSFP, in which fat and water are typically out of phase 
due to the frequency offset of fat [125]. Complex interfer-
ence between fat and water signals leads to counterintuitive 
results: for smaller fat fractions, around 0.5–40% [29, 126], 
an increase in the apparent myocardial T1 occurs; higher 
fat fractions lead to undefined T1 estimates; and fat-like T1 
values are seen only at the highest fat fractions. In chronic 
MI, fat fractions typically do not exceed 35% [29], and 
thus a positive T1 estimation bias is expected, assuming fat 
and water are out of phase. This reduces the specificity of 
native T1 mapping in chronic MI, because similar, but gen-
uine, changes occur in oedema or inflammation. It is cur-
rently unclear what effect fatty changes have on ECV. See 
Fig. 7 for a plot of water and fat signals in bSSFP, along 
with a native T1 map acquired in a chronic MI patient with 
lipomatous metaplasia.
The complex impact of fat partial volume in T1 map-
ping might only reliably be reduced by replacing bSSFP 
with spoiled GRE imaging, in which the fat phase-dif-
ference depends purely on the TE. However, the reduced 
SNR of spoiled GRE relative to bSSFP would have to be 
considered. Alternatively, quantitative myocardial fat-frac-
tion mapping could be applied [127], as recent work has 
incorporated fat–water separation into MOLLI and SASHA 
T1 mapping in skeletal muscle [128] and the heart [32].
Diffuse myocardial fibrosis
Several pathologies cause diffuse fibrosis of the myocar-
dium, such as hypertrophic and dilated cardiomyopathies 
(HCM and DCM), atrial fibrillation, aortic stenosis, heart 
failure with reduced or preserved ejection fractions (HFrEF 
and HFpEF), congenital heart disease, hypertension [129], 
and diabetes [130]. Certain drug therapies, such as alkylat-
ing agents in chemotherapy, can also lead to diffuse fibrosis 
[131], and possibly benefit from applications of T1 map-
ping [132].
In general, native T1 values are increased in diffuse 
fibrosis, but not to as great an extent as in oedema or amy-
loidosis, and ECV is also slightly elevated. In general, scat-
ter in estimated T1 values seems to be of a similar order to 
that seen in diffuse-fibrosis changes, and this has delayed 
the wider uptake of T1 mapping. Several investigators have 
shown the usefulness of ECV as a prognostic indicator 
[133, 134], but there seems to be little progress in taking 
this towards a per-patient test. In many applications there 
is a mixture of focal and diffuse fibrosis, which begs the 
question whether visible focal fibrosis was excluded from 
ROIs used in diffuse fibrosis studies [135], and even if so, 
what “mesoscopic” or “microscar” subvoxel focal fibrosis, 
or other myocardial changes, might be included in the so-
called diffuse fibrosis assessment by T1 [136] (Fig. 8).
Fig. 7  The effect of intramyocardial lipids on native T1 estimation in 
chronic myocardial infarction. The balanced steady-state free-preces-
sion off-resonance response is shown for myocardium and fat (a), for 
a modified Look–Locker inversion recovery protocol with a repetition 
time of 2.8 ms and a flip-angle of 35°. When fat and water are out 
of phase, lipids typically show an elevated T1 in T1 maps; when they 
are in-phase, lipid T1 typically appears lower than myocardial T1. An 
example native T1 map (b), acquired at 1.5T in a chronic myocardial 
infarction patient with lipomatous metaplasia, shows a reduced appar-
ent T1 associated with lipid signals (white arrow). Both the accuracy 
and precision of native T1 estimates are influenced by this effect. Fig-
ure (b) was provided courtesy of Dr Heerajnarain Bulluck, The Hatter 
Cardiovascular Institute, University College London
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Clearly there is substantial overlap between native T1 and 
ECV values measured in controls versus those measured in 
patients with likely diffuse fibrosis. This is partly due to the 
small changes seen in diffuse fibrosis, particularly early in 
the disease when reversing it would be of great clinical ben-
efit before irreversible damage occurs to the myocardium. 
It is also related to the many sources of dispersion in T1 
parameter estimation. As yet, it appears that there is no one 
factor that can be adjusted to achieve adequate T1 estimation 
precision for detecting early diffuse fibrosis. Many recently 
reported clinical studies naturally retained older T1 mapping 
protocols, due to the constraints of their study length, or 
follow-up periods in the “prognosis” papers. Despite these 
problems on the individual level, which may be overcome 
by stricter control of errors, T1 mapping of diffuse fibrosis 
offers concrete benefits in large-scale studies: offering a 
means of testing treatment effects and characterising differ-
ences on a population level [130, 137].
Summary of clinical sources of error
Both native T1 and ECV are important clinical measures that 
allow us to characterise the myocardium in a fashion com-
plementary to LGE. The substantial overlap of these meas-
ures between patients and controls in some cardiac condi-
tions offers challenges to the clinical use of T1 mapping, at 
least with current methodology. However, in specific condi-
tions, such as amyloid and Anderson-Fabry disease, T1 map-
ping has an important diagnostic and prognostic role, and is 
being widely adopted into routine clinical use.
Future directions of T1 and ECV mapping
Potential future solutions for errors in T1 and ECV map-
ping have been discussed throughout this review. We will 
now highlight several promising areas of development that 
may determine the future directions of the field.
Free-breathing T1 mapping would appear to offer major 
gains with regards to T1 mapping accuracy and precision, 
as well as enabling scanning of patients with compromised 
breath-holding. There are already several publications dem-
onstrating the benefits of free-breathing T1 mapping [36–
39]; however, the added time required for these methods 
will limit their wider uptake, unless retrospective image 
registration can be robustly applied.
Certain recent implementations of myocardial T1 map-
ping have incorporated simulations to improve the accuracy 
of bSSFP MOLLI [41, 138, 139], to enable spoiled GRE 
T1 mapping [59], and to reduce the number of pause inter-
vals between Look–Locker sets [140]. As yet, these meth-
ods do not offer an advantage in precision over the original 
MOLLI implementation, but further work may demonstrate 
benefits to their use [138].
Simultaneous T1, T2, and proton density mapping of the 
myocardium is also possible [141–144], with some meth-
ods being feasible in a single breath-hold [142–144]. Mag-
netic resonance fingerprinting is an extension of simula-
tion-based methods that can offer T1, T2, and proton density 
maps [145], as well as other parameters modelled in the 
dictionary. It has recently been adapted to the heart [146]; 
however, further work is required, as currently it shows 
Fig. 8  Structural remodelling 
of myocardium in hyperten-
sion. Subvoxel heterogeneity 
can be seen in cardiomyo-
cyte size, which ranges from 
hypertrophied to atrophied, and 
in fibrosis, which consists of 
microscopic scars, and perivas-
cular and interstitial fibrosis. 
Reproduced with permission 
from Weber et al. [136]
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inferior precision to conventional T1 mapping and requires 
long computation times for pattern matching.
Sacrificing T1 accuracy for increased clinical 
utility
Placing a particular T1 estimate in a local normal range 
may necessitate high precision, but not high accuracy. 
Indeed, accuracy may be sacrificed deliberately to yield 
T1 estimates that are better able to discriminate normal tis-
sue from pathology. For example, increasing the MOLLI 
excitation flip angle to 50° increases sensitivity to off-res-
onance, which reduces T1 accuracy, but also increases MT 
effects, which differ between tissue types. This appears 
effective in detecting diffuse fibrosis in the septum [30, 
147]. The accuracy of this approach is limited, but the 
“true” T1 is less relevant if local normal ranges are used, as 
they should be for any T1 mapping implementation, under 
current guidelines [13].
Conversely, accuracy is important for establishing myo-
cardial T1 and ECV as clinical biomarkers using normal 
ranges that are transferable between sites and vendors 
[148].
Summary
This review has discussed reasons for inaccuracy and 
imprecision in T1 and ECV mapping, and it should be clear 
from these considerations that users should take great care 
when deviating from manufacturers’ advised T1 mapping 
protocols. While improving the apparent quality of maps 
and source images, users may inadvertently reduce the 
precision of T1 estimates, damaging clinical utility. What-
ever T1 mapping setup is used, it is essential that its perfor-
mance is characterised in local normal ranges, and that it is 
applied only for those clinical questions that its precision 
can support. Ongoing quality control and reassessment is 
also required to ensure a local normal range remains valid; 
the reader is referred to the upcoming SCMR and EACVI 
consensus for recommendations in this regard.
In the research and clinical applications described here, 
current native T1 and ECV mapping methods show utility 
in groupwise comparisons through to individual clinical 
tests. For some conditions, like diffuse fibrosis, mapping 
methods serve as weakly prognostic biomarkers that might 
be beneficial in combination with other diagnostic informa-
tion about an individual patient. In other, albeit quite rare, 
conditions native T1 and ECV mapping can provide strong 
diagnostic data.
Fundamentally, cardiac mapping methods have not 
changed radically since Messroghli et al. first introduced 
MOLLI [1]; however, their diversity offers challenges to 
inter-centre use, and new developments and quality con-
trols are still evolving. New approaches that incorporate 
various forms of undersampling and modelling, such as 
fingerprinting, do not currently offer substantial gains in 
accuracy and precision, other than avoiding dependence on 
breath-holding in some cases.
It remains unclear how much of the scatter observed in 
T1 estimates is due to physiological differences in true T1, 
or how much might be eliminated if the potentially cor-
rectable issues discussed here could be addressed robustly. 
If these pitfalls can be accounted for simply, quickly, and 
reliably, without need for specialist attention, T1 and ECV 
mapping may ultimately support more widespread clinical 
applications.
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